Table 4

Procedural characteristics and outcome for GA and non-GA patients after propensity score matching

All, n=308GA, n=153Non-GA, n=153P values
Valve type
 Edwards Sapien168 (54.9)88 (57.5)80 (52.3)0.421
 Medtronic CoreValve138 (45.1)65 (42.5)73 (47.7)
Delivery approach
 Percutaneous282 (92.2)139 (90.8)143 (93.5)0.524
 Surgical cut down24 (7.8)14 (9.2)10 (6.5)
Procedural imaging
 Transoesophageal echocardiogram104 (34.0)52 (34.0)52 (34.0)> 0.999
 None or others202 (66.0)101 (66.0)101 (66.0)
Predeployment balloon valvuloplasty166 (54.2)86 (56.2)80 (52.3)0.566
Postdeployment balloon dilatation30 (9.9)13 (8.7)17 (11.1)0.565
Successful valve deployment291 (95.7)148 (96.7)143 (94.7)0.411
Aortic regurgitation at the end of the procedure, any degree151 (51.7)73 (49.3)78 (54.2)0.415
Aortic regurgitation at the end of the procedure, more than mild15 (5.1)5 (3.4)10 (6.9)0.193
Conversion to full sternotomy1 (0.3)0 (0.0)1 (0.6)>0.999
Acute kidney injury within 7 days of the procedure17 (5.7)6 (4.0)11 (7.4)0.222
New dialysis before discharge3 (0.9)2 (1.2)1 (0.6)0.615
Tamponade during or after procedure4 (1.3)1 (0.7)3 (2.0)0.623
Cerebrovascular attack up to discharge8 (2.6)5 (3.3)3 (2.0)0.723
Major or life-threatening bleeding20 (6.6)11 (7.2)9 (6.0)0.818
Vascular access site complications34 (11.3)19 (12.4)15 (10.1)0.587
Procedure time (min)132.1±62.4140±60.1125±63.20.040
Length of stay in hospital (days)6.5±5.87.4±6.45.6±4.90.008
  • Values are mean±SD or n (%).

  • GA, general anaesthesia.